Insurance status impacts overall survival in Burkitt lymphoma

References

• Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9:222–231.
   PubMed Web of Science ®Google Scholar
• Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9–31.
   PubMed Web of Science ®Google Scholar
• Ward EM, Fedewa SA, Cokkinides V, et al. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J. 2010;16:614–621.
   PubMed Web of Science ®Google Scholar
• Martin S, Ulrich C, Munsell M, et al. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12:816–824.
   PubMed Web of Science ®Google Scholar
• Teras LR, DeSantis CE, Cerhan JR, et al. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443–459.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Fedewa SA, Chen AY, et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012;21:1520–1530.
   PubMed Web of Science ®Google Scholar
• Shih YC, Elting LS, Halpern MT. Factors associated with immunotherapy use among newly diagnosed cancer patients. Med Care. 2009;47:948–958.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242.
   PubMed Web of Science ®Google Scholar
• Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:3121–3127.
   PubMed Web of Science ®Google Scholar
• Han X, Kilfoy B, Zheng T, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973–2003. Cancer Causes Control. 2008;19:841–858.
   PubMed Web of Science ®Google Scholar
• Project TIN-HsLPF. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Parikh RR, Grossbard ML, Green BL, et al. Disparities in survival by insurance status in patients with Hodgkin lymphoma. Cancer. 2015;121:3515–3524.
   PubMed Web of Science ®Google Scholar
• Han X, Jemal A, Flowers CR, et al. Insurance status is related to diffuse large B-cell lymphoma survival. Cancer. 2014;120:1220–1227.
   PubMed Web of Science ®Google Scholar
• Molyneux EM, Rochford R, Griffin B, et al. Burkitt's lymphoma. Lancet. 2012;379:1234–1244.
   PubMed Web of Science ®Google Scholar
• Costa LJ, Xavier AC, Wahlquist AE, et al. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood. 2013;121:4861–4866.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Winer ES, Stachurski D, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymph. 2010;51:2047–2053.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125:2323–2330.
   PubMed Web of Science ®Google Scholar
• American College of Surgeons. National Cancer Database. Available at: https://www.facs.org/quality-programs/cancer/ncdb.
   Google Scholar
• Robert SA. Community-level socioeconomic status effects on adult health. J Health Soc Behav. 1998;39:18–37.
   PubMed Web of Science ®Google Scholar
• Robert SA, Strombom I, Trentham-Dietz A, et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004;15:442–450.
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. 2008–2012 American Community Survey 5-year estimates.
   Google Scholar
• Greene FL, Page DL, Fleming DL, et al. American joint committee on cancer staging manual. New York, NY: Springer-Verlag; 2002.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
   PubMed Web of Science ®Google Scholar
• Bradley CJ, Given CW, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care. 2003;41:722–728.
   PubMed Web of Science ®Google Scholar
• Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. Blood. 2014;124:2913–2920.
   PubMed Web of Science ®Google Scholar
• Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–1580.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Pittaluga S, Shovlin M, et al. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med. 2013;369:1915–1925.
   PubMed Web of Science ®Google Scholar
• Shartzer A, Long SK, Anderson N. Access to care and affordability have improved following affordable care act implementation: problems remain. Health Aff (Millwood). 2016;35:161–168.
   PubMed Web of Science ®Google Scholar
• Sommers BD, Gawande AA, Baicker K. Health insurance coverage and health – what the recent evidence tells us. N Engl J Med. 2017;377:586.
   PubMed Web of Science ®Google Scholar
• Robbins AS, Han X, Ward EM, et al. Association between the affordable care act dependent coverage expansion and cervical cancer stage and treatment in young women. JAMA 2015;314:2189–2191.
   PubMed Web of Science ®Google Scholar
• Loehrer AP, Song Z, Haynes AB, et al. Impact of health insurance expansion on the treatment of colorectal cancer. J Clin Oncol. 2016;34:4110–4115.
   PubMed Web of Science ®Google Scholar
• Sommers BD, Long SK, Baicker K. Changes in mortality after Massachusetts health care reform: a quasi-experimental study. Ann Intern Med. 2014;160:585–593.
   PubMed Web of Science ®Google Scholar
• Sommers BD, Baicker K, Epstein AM. Mortality and access to care among adults after state Medicaid expansions. N Engl J Med. 2012;367:1025–1034.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Winer ES, Olszewski AJ. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the surveillance, epidemiology, and end results database. Cancer. 2013;119:3672–3679.
   PubMed Web of Science ®Google Scholar
• Loghavi S, Alayed K, Aladily TN, et al. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol. 2015;8:65.
   PubMed Web of Science ®Google Scholar
• Mukhtar F, Boffetta P, Risch HA, et al. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000–2013. Int J Cancer. 2016;140:1494–1502. .
   Web of Science ®Google Scholar
• Richardson LD, Norris M. Access to health and health care: how race and ethnicity matter. Mt Sinai J Med. 2010;77:166–177.
   PubMed Web of Science ®Google Scholar
• House JS, Kessler RC, Herzog AR. Age, socioeconomic status, and health. Milbank Q. 1990;68:383–411.
   PubMed Web of Science ®Google Scholar
• House JS, Lepkowski JM, Kinney AM, et al. The social stratification of aging and health. J Health Soc Behav. 1994;35:213–234.
   PubMed Web of Science ®Google Scholar
• Han X, Jemal A, Hulland E, et al. HIV infection and survival of lymphoma patients in the era of highly active antiretroviral therapy. Cancer Epidemiol Biomarkers Prev. 2017;26:303–311.
   PubMed Web of Science ®Google Scholar
• Oriol A, Ribera JM, Bergua J, et al. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer. 2008;113:117–125.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Nastoupil LJ. Socioeconomic disparities in lymphoma. Blood. 2014;123:3530–3531.
   PubMed Web of Science ®Google Scholar
• Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925–934.
   PubMed Web of Science ®Google Scholar
• Mead GM, Sydes MR, Walewski J, et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol. 2002;13:1264–1274.
   PubMed Web of Science ®Google Scholar